| Oversonic Robotics To Supply Humanoids To STMicroelectronics' Semiconductor Plants | GENEVA (dpa-AFX) - Oversonic Robotics announced the signing of an agreement with STMicroelectronics (STM) for the introduction of custom RoBee cognitive humanoid robots into the production and... ► Artikel lesen |
| Oversonic Robotics signs humanoid robots supply agreement with STMicroelectronics | Oversonic to supply custom humanoids to ST's global network of semiconductor plantsCollaborative demo during CES MILAN, Dec. 22, 2025 /PRNewswire/ -- Oversonic Robotics, an Italian company... ► Artikel lesen |
| STMicroelectronics N.V.: Resolutions approved at the Extraordinary General Meeting of Shareholders | Resolutions approved at the Extraordinary General Meeting of Shareholders Amsterdam, December 18, 2025 - STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the... ► Artikel lesen |
| VivoSim Labs, Inc.: VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer | SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim Labs"), a pharmaceutical and biotechnology services company that is focused on providing testing... ► Artikel lesen |
| INOVIO Pharmaceuticals, Inc.: INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights | Completed rolling Biologics License Application (BLA) submission seeking accelerated approval for lead candidate INO-3107; requested priority review
Expect... ► Artikel lesen |
| INOVIO Pharmaceuticals, Inc.: INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults | Recurrent respiratory papillomatosis (RRP) is a rare HPV-related disease of the respiratory tract with significant unmet need
INO-3107 previously received... ► Artikel lesen |
| INOVIO Pharmaceuticals, Inc.: INOVIO Reports Inducement Grant Under Inducement Plan | PLYMOUTH MEETING, Pa., Oct. 31, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help... ► Artikel lesen |